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Abstract 
Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease and major cause of disability. COPD may 
be considered a systemic disease, which causes an array of symptoms, one of which is the subjective sensation 
of fatigue. In recent years, COPD related fatigue (COPD-RF) has increasingly been recognised as an important 
area of research. The aim of this paper is to comprehensively review the literature concerning this topic and to 
summarise existing knowledge on the subjective perception of fatigue in people with COPD. This paper 
provides a narrative review of literature in this area. The search used the electronic databases of OVID 
MEDLINE and EMBASE included original studies from 1980 to December 2011. The databases were searched 
using the key MeSH terms COPD and Fatigue.  
In total 40 relevant publications were identified. This literature review covers the following areas identified by 
research studies: fatigue in COPD in comparison with healthy older people, gender differences, patients’ 
experience of fatigue, prevalence of fatigue reporting in COPD, pattern and frequency of fatigue in COPD, the 
impact of fatigue on an individual’s life, predictors of fatigue, coping and treatment strategies for the 
management of fatigue. Furthermore, this review identifies areas for further research and makes 
recommendations for clinical practice.  
Keywords  
COPD – Chronic Obstructive Pulmonary Disease, Disease Management, Fatigue, Prevalence, Symptoms 
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Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease and a major cause of disability. Although 
the disease primarily affects the respiratory system, there are also major systemic consequences [1;2]. COPD 
causes an array of symptoms, one of which is the subjective sensation of fatigue. There are several studies 
addressing this perception of fatigue in COPD [3-5]. However, there are differences in definitions, interpretation 
and assessment of fatigue, resulting in confusion and making comparison between studies difficult. The 
sensation of fatigue may be defined in various ways as tiredness [6], lack of energy [7], exhaustion or weakness 
[8]. Studies identify fatigue in a variety of ways: as one of the symptoms of the disease [8;9], patients’ 
complaint [7], a subjective multi-component experience [3;10], part of general health measure [11;12] or an 
independent variable affecting many areas of a patient’s health and functioning [4;13]. Fatigue may be 
considered as an independent phenomenon with diverse manifestations, such as physical or mental tiredness, 
loss of attention, concentration or motivation [14]. There are also various theories [15], hypothesised models 
[4;16] and measurement of fatigue [17;18]. Consequently, with such a diverse interpretation of fatigue in COPD 
studies, there are many methods of assessment. 
The aim of this literature review is to summarise existing knowledge concerning the subjective perception of 
fatigue in people with COPD. Using a comprehensive and systematic approach this review attempts to cover the 
following areas identified by research studies: fatigue in COPD in comparison with healthy older people; gender 
differences; patients’ experience of fatigue; prevalence of fatigue reporting in COPD; pattern and frequency of 
fatigue in COPD; the impact of fatigue on an individual’s life; predictors of fatigue; coping and treatment 
strategies for fatigue management. Furthermore, this review identifies areas for further research in COPD-
Related Fatigue (COPD-RF) and makes recommendations for clinical practice. 
Methods 
This paper provides a narrative review of literature in this area. The search strategy used the electronic databases 
of OVID MEDLINE and EMBASE. The databases were searched by using the key MeSH terms ‘COPD’ and 
‘Fatigue’. Studies from 1980 to December 2011 were included in the search. The titles and abstracts of all 
obtained studies were assessed and relevant studies identified. In addition, the reference lists of the obtained 
articles were examined for additional publications. Only original quantitative and qualitative studies in English 
language, which involved a COPD population and considered assessment of fatigue as a subjective sensation 
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were included. Meta analyses were considered. Concept analyses and descriptive review papers as well as 
studies focused on muscle fatigue mechanisms were excluded.  
Results 
Search for literature in OVID found 647 papers, however, most of them irrelevant or considering skeletal and 
respiratory muscle fatigue measures. After abstract assessments and search for duplicates 33 papers were 
identified. Further reference screening added 5 more papers. Moreover, one Cochrane review and conference 
data relevant to the subject were included. In total data from 40 papers were extracted and reviewed.  
 
Comparison of subjective fatigue between patients with COPD and healthy older people  
A fundamental question concerning fatigue in COPD relates to age adjusted norms; is fatigue a feature of the 
disease or is it merely a reflection of ageing? There were three studies, which considered comparison of fatigue 
between COPD patients and healthy subjects. Theander and Unosson [19] addressed this specific question in a 
comparison study between 36 COPD patients and 37 healthy age-matched subjects. The assessment consisted of 
severity, frequency, duration and functional impact of fatigue (Fatigue Impact Scale (FIS), validated by 
Theander and colleagues [20]). In all components of fatigue assessment COPD patients had significantly higher 
scores compared with healthy controls. However, 40% of the subjects in the control group had illnesses other 
than COPD and consequently, may not be considered ‘healthy’. Moreover lung function was not measured in 
either the COPD or control group and accurate characterisation of control group or the disease severity was not 
possible. More recently Baghai-Ravary and colleagues [13] studied 107 patients with moderate COPD and 30 
healthy controls. The groups were adequately age-matched and subjects or patients with a history of other 
significant diseases were excluded from both groups. Fatigue was measured using the Functional Assessment of 
Chronic Illness Therapy- Fatigue (FACIT-F) Scale. This unidimensional scale was originally developed for 
cancer patients and is untested in a COPD population. In this study, COPD patients scored significantly lower 
on the FACIT-F scale than healthy controls, indicating higher levels of fatigue that are unrelated to age. 
However, this unidimensional tool gives only general results about fatigue and provides little information on 
particular aspects of fatigue such as mental or physical components. Finally, published data from Lewko et al. 
[21] compared a multidimensional fatigue score between 74 mild-to-severe COPD patients and 35 healthy age-
matched subjects. There were no significant differences between groups according to age, BMI and body 
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conposition. For this study the Multidimensional Fatigue Inventory (MFI-20) was used to measure 5 
components of fatigue: general, physical, mental, reduced activity and motivation. The results indicated that all 
dimensions of fatigue are significantly impaired in COPD patients compared with healthy people of a similar 
age. In summary, two adequately powered studies suggest that fatigue is an independent feature of COPD. For 
details see table 1. 
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Table 1. Comparison of fatigue between COPD patients and healthy older people - evidence summary   
First author 
Year 
published 
Study 
type 
Sample size 
Control group 
Mean age 
(SD)        
% pred. FEV1 
(SD) 
Fatigue 
assess. 
tool 
Tool type Fatigue comparison General comments 
COPD  Control  
COPD v. Healthy 
 Theander[20]  2007 Cross-
section 
study 
36 37 age-matched general 
population (15 with a 
diagnosis of non-COPD 
chronic conditions) 
 Men 68 (5.3) 
and women 
63 (4.6) 
 v.  Men 66 
(5.2) and 
women 62 
(5.8) 
data not 
available 
FIS multi-
dimension 
all dimensions of 
fatigue significantly 
increased in COPD 
v. Healthy (p<0.001, 
cognitive fatigue 
p<0.05) 
small sample size, 
control group non 
disease free, FEV1 
not assessed 
 Baghai-Ravary 
[13] 
2008 Cross-
section 
study 
106 30 age-matched, 
 no COPD or other 
respiratory disease, 
FEV1/FVC >70%, no 
malignant, 
immunodeficiency or 
significant inflammatory 
disease  
69.4 (8.2) v.  
68.6 (6.1) 
53.1 (21.1)% 
v.  
94.1 (16.9)% 
FACIT-
Fatigue 
uni-   
dimension 
Increased fatigue in 
COPD compared to 
healthy (p=0.001) 
adequate sample 
size, healthy age-
matched control 
group 
Lewko [21] 2009 Cross-
section 
study 
74 35 age-matched no airway 
obstruction, no 
significant inflammatory 
co-morbidities or 
unstable angina, no 
psychiatric diagnosis  or 
mobility limitations  
69.9 (8.4) v.  
67.1 (8.8.) 
46.5 (20.0)% 
v. 
96.5 (13.2)%  
MFI-20 multi-
dimension 
all dimensions of 
fatigue are 
significantly 
increased in COPD  
compared with 
healthy control (p 
<0.001) 
adequate sample 
size, healthy age-
matched control 
group 
% pred. FEV1: percent predicted Forced Expiratory Volume in one second; FEV1/FVC :  ratio  Forced Expiratory Volume in one second / Forced Vital Capacity; FIS: Fatigue Impact Scale ; FACIT-
Fatigue: Functional Assessment of Chronic Illness Therapy- Fatigue; MFI-20: Multidimensional Fatigue Inventory
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Gender differences in fatigue  
One study [7] of 56 male and 48 female stable COPD patients investigated fatigue using a self designed scale 
and the fatigue subscale of Short Form 36 (SF-36) questionnaire. They found no significant differences in 
fatigue according to gender. However, the women were significantly younger and with more severe airway 
limitation when compared to men. In addition the tool used lacked validation in the population. Other study [4] 
of adequately matched COPD men (n=68) and women (n=62) used a range of fatigue assessment tools including 
Numeric Rating Scale (NRS), Profile of Mood Scale (POMS) and Fatigue Assessment Inventory (FAI). Gender 
differences were seen in selected areas of the assessment. Fatigue was more intensive and distressing in women 
than in men and situation specific FAI score was similarly higher in women. However, there were no gender 
differences for other fatigue assessments. Although these authors assessed fatigue in a variety of ways there was 
no evaluation of physical or mental components. A recent large study by Theander and Unosson [22] 
investigated fatigue with respect to gender in COPD and healthy groups. Three hundred forty five COPD 
patients (150 male) were asked to indicate the frequency, duration and severity of fatigue and to complete FIS. 
Mean age (SD) for COPD male and female was statistically significantly different (65 (7.9) and 63 (8.3) years, 
respectively). There were no significant differences in fatigue between COPD men and women, as oppose to the 
findings in healthy subjects. However, it is difficult to know whether gender difference would have persisted if 
the groups were adequately age-matched. In one other study [21], there was also no evidence of differences in 
fatigue according to gender in COPD patients, although this was a secondary outcome of this study and 
characterisation of gender groups was inadequate. For study details see table 2. 
In summary, there is some evidence based on data of limited quality currently available to suggest that men and 
women with COPD are equally affected by fatigue. However, women may experience more intense and 
distressing fatigue than men.  
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Table 2.  Gender differences in fatigue- evidence summary. 
 
First author 
Year 
published 
Study 
type 
Sample size 
Study population 
Mean age 
(SD)        
% pred. FEV1 
(SD) 
Fatigue 
assess. 
tool 
Tool type 
Fatigue 
comparison 
General comments 
Male Female 
Male v. Female 
Gift [7] 1999 
Cross-
section 
study 
56 48 
stable COPD, not 
smoking, no 
psychologic diseases 
62 v. 58  24 v. 20%  
fatigue 
scale, 
SF-36 
fatigue  
self-design, 
subscale of 
QoL scale 
no gender 
differences 
Not validated tool used, 
significant age and FEV1 
differences between men 
and women 
Kapella [4] 2006 
Cross-
section 
study 
68 62 
moderate-to severe 
stable COPD, FEV1 
predicted <70%, no 
Asthma, surgery or 
Pulmonary 
Rehabilitation 
recently 
69.5(5.8) v. 
68.7(6.7) 
44.5 (17.9)% v. 
46.1 (18.4) % 
NRS-
fatigue, 
POMS-
Fatigue, 
FAI 
Uni and 
multi-
dimension 
fatigue intensity 
and distress, FAI 
situation specific 
higher in women, 
no gender 
differences for 
POMS-F, NRS 
fatigue, other FAI 
scores 
relevant sample size, 
variety of fatigue tools, 
but no physical and 
psychological dimensions 
included 
Lewko [21] 2009 
Cross-
section 
study 
52 22 
stable COPD, no other 
significant co-
morbidities 
total                         
69.9 (8.4) 
total            
46.5 (20.0) %  
MFI-20 
multi-
dimension 
no gender 
differences 
age and FEV1 for men and 
women separately not 
published 
Theander [22] 2011 
Cross-
section 
study 
150 193 
COPD, 75 yrs old or 
younger 
65(7.9) v. 
63(8.3) 
(p=0.01) 
data not 
available 
FIS 
multi-
dimension 
no gender 
differences 
large sample size, 
significant age difference 
between men and 
women, no FEV1 
measured 
 % pred. FEV1: percent predicted Forced Expiratory Volume in one second; SF-36: Short Form 36; QoL: Quality of Life; NRS: Numeric Ratio Scale; POMS-F: Profile of Moods Scale- Fatigue; FAI: 
Fatigue Assessment Inventory; FIS: Fatigue Impact Scale; MFI-20: Multidimensional Fatigue Inventory. 
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Subjective experience of fatigue in COPD 
 
Since fatigue is a subjective experience, it is inevitably perceived differently amongst individuals. One 
qualitative study on 17 COPD patients [5] used a structured interview to elucidate further patient perception of  
fatigue; these mild-to-severe patients described feeling generally tired; reported a lack of energy and a decreased 
ability to concentrate. Patients indicated that fatigue was present in conjunction with “laboured breathing” and 
brought on by activities such as climbing the stairs, walking uphill or by environmental factors, such as tobacco 
smoke or cold and windy weather. Importantly, the COPD subjects indicated that the feeling of fatigue occurs 
more quickly and after lower intensity exertion compared to fatigue experienced by a healthy person.  
In another study exploring subjective fatigue in COPD, Kapella and colleagues [4] reported that 70% of patients 
stated that “current fatigue is different in quality and intensity than the fatigue they experienced before 
developing this condition [COPD]”  and that fatigue did not predate any other symptoms. Only half of male 
participants indicated that exercise brought about fatigue (52%) but that fatigue was reduced by rest (73%), 
sleep (75%) or cool temperature (68%). Ream and Richardson [23] explored the experience of fatigue in 6 
COPD subjects. One subject described fatigue as a feeling of ‘exhaustion’, which followed strenuous physical 
activity and was accompanied by aching. Patients complained of poor concentration and lack of “get up and go”, 
which may be considered as dampened motivation. Fatigue evokes the feeling of depression, constant low mood 
and low self-esteem. Patients reported that due to their fatigue and illness, they did not feel in control and 
missed “the person they used to be” before their illness. Inevitably fatigue contributes significantly to impaired 
quality of life (QoL) in patients with COPD and as a multi-component symptom reflects aspects of motivation, 
physical ability, mood states and cognitions. 
The prevalence of fatigue in COPD 
There are various studies investigating the prevalence of fatigue in COPD; however methodological differences 
in studies have led to differing results. Factors of importance include disease severity and stability, time from 
last exacerbation, co-morbidities and differences in assessment of fatigue itself.  In an early study of Kinsman 
and colleagues [8], the Bronchitis-Emphysema Symptom Checklist (BESC) was used to examine the frequency 
of fatigue symptoms. One hundred and forty six patients were asked during their hospitalisation, how often they 
experienced fatigue “during periods of difficult breathing”. The study reported a high prevalence of fatigue with 
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91% of patients complained of experiencing fatigue at least sometimes and 43% “almost always” and “always”. 
However, in this study, patients were reporting fatigue as a feature of an exacerbation limiting the generalisation 
to a stable population; in addition the patients were poorly characterised. Using the same tool, Graydon and 
colleagues [24] assessed 71 severe COPD patients at 6-month intervals for 2.5 years. Fatigue prevalence in this 
cohort of patients was between 59% initially and 62% at final assessment and did not increase significantly over 
time, supporting the idea of lower (although still clinically relevant) levels of fatigue during a period of relative 
stability.  
In a later study by Gift and Shepard [7], a self design questionnaire was used and validated by correlation with 
the SF-36 fatigue subscale in 104 COPD severe patients. Fifty eight percent of patients reported experiencing a 
lack of energy during previous week. The authors also suggested that a combination of fatigue and dyspnoea led 
the patients to seek health care. This was confirmed in a recent study of Vandevoorde et al. [6], which included 
146 smokers aged 40-70 yrs old from GP surgeries. Only 17% had a confirmed diagnosis of COPD while just 
fewer than 30% were newly diagnosed after performing a spirometric assessment. Subjective symptom of 
fatigue was assessed using a question ‘Are you tired more easily than before?’. The prevalence of fatigue was 
around 47% for all COPD patients, but was significantly higher in the group with previously known COPD 
(68%) compared with the newly detected cases (35%). Although the method of fatigue assessment can be 
criticised and the reported prevalence may be subject to error, this study showed fatigue as an important 
independent factor, which may help detect COPD in a high risk population.  
Walke and co-workers [25] assessed a fatigue symptom using the modified Edmonton Symptoms Assessment 
Scale (ESAS) in 74 COPD patients, and followed this up after 24 months. Fatigue, together with shortness of 
breath and physical discomfort, were the most prevalent symptoms. The prevalence of fatigue was 69% (50% 
moderate-to-severe) at the beginning and 92% (62% moderate-to-severe) at the end of the study. It was in 
contrast with previously reported findings [24]. However, the study population was older than in previous 
studies and inclusion criteria indicate higher severity of airflow obstruction. Another study of Walke group [9] 
used the ESAS in 81 COPD of patients and recorded lower fatigue prevalence of 49%. This prevalence was, 
however, comparable to previous study’s report on moderate-to-severe fatigue. Yet it remains unclear whether 
the difference derived from this change of reporting criteria. A similar prevalence was reported in a recent study 
of Peters et al. [26]. The study included 168 stable moderately severe COPD with mean age of 64.5. Fatigue was 
measured using a subscale of the Checklist Individual Strength (CIS). Abnormal (>26) fatigue score was present 
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in 47.6% of patients including 24.4% of severely fatigued patients. Furthermore, half (n=77) of these patients 
were followed up after 4 years. In this sub-cohort the percent of abnormal fatigue increased from 45.5% to 
63.7% at follow up. Fatigue score increased in over 30% of patients and severe fatigue was reported in 41.6%. 
This study provides the longest fatigue follow up data, showing an increase in fatigue over the time. These 
variations in prevalence may be further explained by differences in co-morbidities or disease severity between 
studies or follow up time. 
Another study investigated symptoms distress and QoL in advanced COPD [27]. The study assessed 100 COPD 
patients with severe airways limitation using the Memorial Symptom Assessment Scale (MSAS). The 
instrument assessed prevalence, frequency, severity and degree of symptoms and included ‘lack of energy’ 
subscale. Lack of energy was the second most prevalent symptom, just after shortness of breath, and it was 
reported by 71% patients.   
A review of symptoms prevalence in end stage COPD and other chronic diseases [28] revealed that 68-80% 
patients complained of fatigue and it was the second most prevalent symptom after dyspnoea. It was a less 
common symptom than in cancer patients, and similar to that of patients with heart disease or AIDS. In a more 
recent study focusing on the last year of life of COPD patients [29], fatigue was experienced by 96% of patients. 
For detailed information see table 3. 
In conclusion, fatigue prevalence ranged from 35% in newly diagnosed patients, 48% in mild COPD, 58-69% in 
patients already diagnosed, 71% in more advanced disease, 92% during ‘difficult breathing’ or disease 
exacerbation and 96% in palliative patients. The prevalence of fatigue in COPD progresses with time and 
disease advancement. Prevalence and perception of fatigue in COPD is clearly dependent upon authors’ 
definition, assessment method or/and disease severity; however the clinical importance of assessing fatigue may 
be undervalued presently.  
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Table 3. The prevalence of fatigue in COPD - evidence summary. 
 
First author 
Year 
published 
Study type 
Sample 
size 
Study population 
Mean 
age 
(SD)        
% pred. 
FEV1 (SD) 
Fatigue 
assess. tool 
Tool type 
Fatigue 
prevalence 
General comments 
Kinsman [8] 1983 
Cross-section 
study 
146 
chronic bronchitis 
and emphysema,  
during period of 
hospitalization 
63 (9) 
data not 
available 
BESC 
symptom 
checklist 
91% 
no current diagnostic criteria 
and no FEV1 measures, data 
collected during acute 
exacerbation   
Graydon [24] 1995 
Cohort 
prospective, 
2.5 years 
longitual 
71 COPD, FEV1 <50% 66.57 31.7 (8.6)% BESC 
symptom 
checklist 
58.6-61.8% 
(not 
significant 
change)  
the tool not tested for 
sensitivity to change, only 
moderate-to-severe patients 
included 
Gift [7] 1999 
Cross-section 
study 
104 
COPD, non-smoker, 
no psychological 
disease  
60 22.6(6.8) % 
a fatigue 
scale  
self-design NRS 
tool  
58% 
54% of patients were using 
oxygen either continuously or 
occasionally, poor validation 
of the tool   
Walke [9] 2004 
Cross-section 
study 
81 
COPD, PCO2 ≥ 45 
mmHg or SpO2 ≤ 
90%, cor pulmonale, 
history of respiratory 
failure or respiratory 
hospitalisation  
72 (7) 
data not 
available 
ESAS 
symptom 
checklist 
49% 
Disease severity unclear, 
COPD patients had similar 
fatigue prevalence to cancer 
(48%) and CHF patients 
(42%), 
Elkington [29] 2005 
retrospective, 
post mortem 
carer survey 
209 last year of life 76.8 
data not 
available 
VOICES 
survey, 
including 
symptom list 
96% 
recall from the carer 5-10 
month after the death may 
create a bias 
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Solano [28] 2006 review 
285  
2 
studies 
advance COPD,             
end of life 
71 (1 
study 
only) 
data not 
available 
no validated 
tool 
semi structured 
interviews and 
survey 
68 and 80% 
data based only on 2 studies 
using different method of 
assessment 
Walke [25] 2007 
cohort , 2 
years 
longitual 
74 
COPD, hospitalisation 
in last 6 months, 
having any 2 of: PCO2 
≥ 45 mmHg, SpO2 ≤ 
90% or cor pulmonale 
or FEV1 <0.5 or 
polycythemia  
72 (7) 
data not 
available 
ESAS 
symptom 
checklist 
69-92% 
(moderate-
to-severe 
50-62%) 
 Data from 45 patients 
available as 29 patients 
deceased during the study. 
Age and disease severity of 
this sub cohort unclear 
Vandevoorde 
[6] 
2007 
population, 
Cross-section 
study 
68 
smokers, age 40-70, 
COPD with FEV1/FVC 
< 70% 
53.9 
(8.9) 
77.5 (16.5) 
% for newly 
diagnosed 
COPD  
GP 
completed 
questionnai
re 
symptom 
checklist 
47.1% 
(34.9%-
68%) 
Not validated tool used 
Blinderman [27] 2009 
Cross-section 
study 
100 
advance COPD, FEV1 
<30%, no psychiatric 
or cognitive disorder 
62.2 
(10.5) 
24.4 (3.9)% 
MSAS 
Lack of 
energy 
multi- 
dimensional 
symptom  
evaluation 
71% 
no fatigue specific 
assessment used 
Peters [26] 2011 
cohort ,  4 
years 
longitual 
168, 77 
after 4 
years  
moderate COPD, no 
exacerbation in 6 
months, no 
pulmonary rehab 
64.5 
(9.1) 
51.6 (13.6)% CIS 
fatigue 
subscale, 
symptom 
checklist 
47.6%, after 
4 years 
63.7%  
adequate sample side,   no 
fatigue specific assessment 
with a cut point not validated 
for COPD 
% pred. FEV1: percent predicted Forced Expiratory Volume in one second; BESC: Bronchitis-Emphysema Symptom Checklist ; ESAS: Edmonton Symptoms Assessment Scale; MSAS: Memorial 
Symptom Assessment Scale; CIS: Checklist Individual Strength ; GP: General Practitioner. 
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Pattern and frequency of fatigue in COPD  
How often fatigue occurs and whether there are diurnal patterns to its presentation are further research areas. In 
one study on 104 COPD subjects, where fatigue was identified as a “lack of energy”, there were on average 2.7  
reports per week of fatigue [7]. In another, qualitative study [5], fatigue was reported to occur every day, 
intermittently throughout the day. In advanced disease, frequency of ‘lack of energy’ is similar to that of 
breathlessness; 67% of patients described it as ‘frequently’ or ‘almost constant’[27]. 
The daily pattern of fatigue is difficult to discern; it may be present in the evening “after a day with usual 
activities”[4] or in may worsen in the afternoon (51%). Half of the responders could not determine morning or 
afternoon prevalence of fatigue. However, one study of temporal variations of symptoms in COPD [30] assessed 
the pattern of fatigue over 8 days. Ten patients were asked to rate their fatigue using the Visual Analogue Scale 
(VAS) at 5 time points a day. A circadian rhythm was identified with fatigue peak time at 16.16 hr, with a 95% 
confidence interval ranging from 14.36 to 17.40 hours. These findings are consistent with some patients’ reports 
from a previous study [4].  
In conclusion, currently available data concerning frequency of fatigue are confusing and fragmented. There are 
some indications from a small study that fatigue peak occurs in the afternoon. However, there is not enough 
evidence to draw generalised conclusion.  
Fatigue impact on patients’ health 
Fatigue has been recognised as an important and common symptom of COPD, which might negatively impact 
patients’ functional status. In patients with mild-to-moderate COPD increased fatigue is associated with a higher 
sick leave from work [31] and higher frequency of exacerbations [4;13]. A recent study [32] showed that higher 
VAS-fatigue was associated with higher disability level in COPD. Fatigue showed negative associations with 
the functional performance [4;33]. However, it is not clear in what way fatigue may contribute to impairment in 
patients’ functional performance. A model analysis by Kapella and colleagues [4] showed that fatigue, 
dyspnoea, airflow limitation and anxious mood, directly affected patients’ functional performance. However, 
according to other study using structural equation modelling [12]. fatigue influenced functional performance 
only indirectly via its impact on negative mood and health perception. This association between fatigue and 
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negative mood was indicated by another regression study [34]. However, due to a small sample size the findings 
could not be considered conclusive. 
Further research shows that patients with COPD report a combination of breathlessness and fatigue, leading to a 
gradual decline in their Activities of Daily Living (ADLs) [5].  Although fatigue did not interfere directly with 
family or friend relationships, it limited social roles. However, in a recent study, it was shown that abnormal 
fatigue levels affect functional impairment, QoL and relationships in COPD patients [26]. This in turn may 
impact on an individual’s activities outside home. In one study, fatigue was the only predictor of reduced time 
spent outdoor [13]. However, in a recent study by Peters et al. [26] physical activity measured by accelerometer 
was not affected by fatigue. This discord may be due to differences in patients’ perception of activity done and 
accelerator measures.  
Moreover, patients who report severe fatigue had more limitations in cognitive, physical and psychosocial 
functioning (FIS) and worse health related QoL (SF-36), compared with those with no fatigue [35]. The impact 
of fatigue on QoL in COPD has been frequently evaluated with authors showing significant relationships 
between higher fatigue and reduced QoL [3;13;36]. Fatigue or lack of energy is a recognised component of QoL 
measures [11] and may be assessed as one of its subscales. However, this may be an oversimplified approach; 
an examination of a pathway analysis model for variables associated with chronic bronchitis and emphysema 
revealed that fatigue did not influence directly QoL nor functional status, but was a mediator of QoL impairment 
through mood disturbance [37]. Prospective testing of this proposed model is warranted.   
Predictors of fatigue in COPD  
Few studies have focused on investigating causes of fatigue in COPD using standardised questionnaires 
[3;4;7;10;13;38;39]. The use of uni- and multidimensional measures has influenced presented results. 
Furthermore, some studies identified associations between fatigue and other variables based only on simple 
coefficient correlations, which could not be as robust as multivariante analysis.  
Generally the studies report an association between fatigue and dyspnoea [4;7;10;13;39;40]. Significant 
correlations were found between unidimensional measures of fatigue and dyspnoea regardless of severity of 
disease [4;7;39]. There was also a significant mild-to-moderate correlation between all dimensions of MFI-20 
and Baseline Dyspnoea Index, where lower score indicates higher dyspnoea (r= -0.27 for Mental fatigue to – 
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0.53 for Physical Fatigue) [10]. However, these studies are limited by the lack of multiple regression analysis 
and adjustment for confounders. The results are, therefore, indicators of direction rather than predictors of 
fatigue.  
Kinsman and collegues [8] used a dyspnoea severity classification (alike Medical Research Council (MRC) 
scale) to evaluate possible associations between fatigue and dyspnoea severity. There were significant 
differences found in the frequency of fatigue (BESC) between groups. These findings have been confirmed in 
another study [13], where fatigue was assessed using the FACIT-F questionnaire and significant differences in 
fatigue according to the MRC grades were found. In other study [21] using MFI-20, differences according to 
MRC dyspnoea grades were evident only for selected dimensions and were not present for Reduced Motivation 
and Mental Fatigue.  
Recently, one small study by Inal-Ince group [36] investigated patients’ fatigue severity and its impact, in 
relation to a grading indices of COPD severity. The BODE and SAFE indices were used to determine patient 
severity groups [41;42]. The study assessed 22 mild-to-very severe COPD males (mean age 62.5 (6.5)) and 
showed significant correlations between fatigue severity (FSS) or fatigue impact (FIS) scales and both BODE 
and SAFE indices. Although the finding indicates association between fatigue and grades of disease severity, it 
is underpowered and a choice of the statistical analysis for a 4-stage grading system may be criticised.  
Moreover, fatigue is related to mood and stress [10], depression [4;10;13] and indirectly to anxiety [4]. 
Depression has been shown to be a significant predictive factor in the fatigue regression analysis [4;13].  
Recently an association between fatigue (Manchester COPD-fatigue questionnaire) and a range of inflammatory 
markers (IL-6, CRP, TNF-α, TNF-α-R1 and TNF-α-R2) in 120 moderate COPD patients were explored [43]. 
There were no significant correlations found between fatigue and any of the markers. However, Borg exertion 
score (RPE) after a walk test correlated weakly with TNF-α only (r=0.23, p=0.01) and at rest with both TNF-α 
and CRP (r=0.24, p=0.01 and 0.19, p=0.05, respectively). These findings may suggest that although chronic 
fatigue is not directly correlated with systemic inflammation in COPD, there is some association between this 
inflammation and acute sensation of tiredness at rest and on exercise.  
Furthermore, fatigue is associated with age [4;44] annual exacerbation rate [4;13], sleep quality [4;10], walking 
test distance [3;39] and muscle strength [38]. A recent large Pan-European study [45] assessed subjective 
fatigue (FACIT-F) in 1817 COPD patients from a primary care population in 7 European countries. A wide 
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range of mild-to-severe COPD patients with mean FEV1 % predicted 56.7(20.1) and average age 64.9 were 
included, 13% of them had acute exacerbation. Fatigue was significantly worse in patients with an exacerbation 
and in patients with 3 or more co-morbidities, but not with cardiovascular co-morbidity alone.  
Nevertheless, studies using a multidimensional assessment of fatigue provide us with more detailed data about 
relationships between dimensions of fatigue and their associates. Each of these variables are associated with 
selected components of fatigue. For example there was a mild significant correlation between sleep quality 
(Pittsburg Sleep Quality) and General, Physical and Mental Fatigue dimensions of MFI-20 but not with Reduced 
Activity [10]; whereas, 6 Minute Walk Test correlated significantly only with Reduced Activity, General and 
Physical dimensions [3] and muscle strength only with Physical Fatigue [38]. In a study using unidimensional 
fatigue assessment, no relationship was evident between fatigue and airway obstruction [4;13]. However, with 
more comprehensive assessment of fatigue using the MFI-20, showed that % predicted FEV1 was related to all 
but Mental Fatigue dimensions [3;10]. Furthermore, there were significant differences in scores for Physical 
Fatigue and Reduced Activity dimensions only, when stratified according to GOLD spirometric stages [21].  
One recent study [44] of 42 older COPD patients aged 72.9± 6.5 years, who were participating in a Pulmonary 
Rehabilitation (PR) programme examined multidimensional fatigue and the relationship between fatigue 
dimensions and anxiety, depression, sleep quality, dyspnoea and other physiological factors. There was a 
moderate, statistically significant correlation between age and Reduced Activity (r=0.43; p=0.05) and Reduced 
Motivation (r=37; p=0.05). Furthermore, anxiety had a significant but negative correlation with the motivational 
dimension (r=-0.47; p=0.01). In contrast with other studies, in this group of COPD patients there was no 
correlation between sleep quality, depression, walking distance or dyspnoea and any dimensions of fatigue. This 
may be explained by the much greater age of the study cohort. Moreover, the study group was not homogenous, 
with patients presented different advancement levels of rehabilitation as both very advanced and novice patients 
were included. Therefore, the findings have to be treated with caution as dynamicity and variation of the group 
has to be considered.  See more studies’ details in table 4. 
  
A Comprehensive Literature Review of COPD-Related Fatigue                                                          CRMR 2012 
 
18 
 
 
Table 4. Correlates of fatigue in COPD- evidence summary. 
First author 
Year 
published 
Study type 
Sample 
size 
Study population 
Mean 
age (SD)        
% pred. 
FEV1 (SD) 
Fatigue 
assess. 
tool 
Tool type Correlates General comments 
Kinsman [8] 1983 
Cross-
section 
study 
146 
chronic 
bronchitis and 
emphysema,  
during period of 
hospitalization 
63 (9) 
data not 
available 
BESC 
symptom 
checklist 
MRC  
correlation used for 
analyses of grading 
scales, non-stable 
disease data, not 
current diagnostic 
criteria 
Breslin [3] 1998 
Cross-
section 
study 
41 stable COPD 62 (8) 
35.8(16.6) 
% 
MFI-20 
multi-
dimension 
 FEV1 % pred. and 
6MWT (only GF, PF 
&RA); depression 
(GF&MF) 
small sample size, 
multiple analyses 
without correction 
Breukink [38] 1998 
Cross-
section 
study 
19 stable COPD 64 (6) 38 (17) % MFI-20 
multi-
dimension 
FEV1 (RA, RM), Borg 
dyspnoea and 
exertion (RM), upper 
& lower muscle 
strength 
very small sample 
size, multiple 
analyses without 
correction 
Gift [7] 1999 
Cross-
section 
study 
104 
stable COPD, not 
smoking, no 
psychologic 
diseases 
60 22.6(6.8)% 
fatigue 
subscale 
SF-36 
subscale 
of QoL 
scale 
dyspnoea, BSI 
physical symptoms, 
BSI somatisation 
severe disease COPD, 
multiple parametric 
tests used for 
nonparametric data 
without correction 
Woo [39] 2000 
Cross-
section 
study 
37 
chronic 
bronchitis, 
emphysema, no 
psychiatric or 
neuromuscular 
disease 
66.9 
(10.6) 
48.1 
(13.6)% 
POMS-F 
subscale 
of the 
Profile of 
Moods 
6MWT (negative), 
Dyspnoea (VAS) 
Pilot study- small 
sample size, not 
fatigue specific tool 
used 
Oh [10] 2004 
Cross-
section 
study 
128 
stable COPD, no 
major co-
morbidities 
64.2 
(11.3) 
64.5 
(28.8)% 
MFI-20 
multi-
dimension 
Overall fatigue: FEV1 
% pred., BDI, 
pulmonary 
symptom, mood, 
stress, sleep quality 
no correction for 
multi-correlation 
analyses 
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Kapella [4] 2006 
Cross-
section 
study 
130 
moderate-to 
severe stable 
COPD, FEV1 pred. 
<70%, no 
Asthma, surgery 
or PR recently 
68.7(6.7) 
-
69.5(5.8) 
44.5 
(17.9)%- 
46.1 
(18.4) % 
NRS 
fatigue, 
POMS-F 
subscale 
of the 
Profile of 
Moods, 
numerical 
scale 
NRS: age, no. of resp. 
Infection; NRS & 
POMS-F: dyspnoea, 
anxiety, depression, 
sleep quality 
not well validated 
tools used,  multiple 
parametric testing 
were used without 
correction 
Baghai- Ravary 
[13] 
2008 
cohort 
study 
107 
stable COPD, 
FEV1/FVC <70% 
69.4 
(8.2) 
53.1 
(21.1)% 
FACIT-
Fatigue 
uni-
dimension 
dyspnoea (MRC, 
VAS), depression 
(CES-D), 
exacerbation rate 
parametric analyses 
were used for non 
parametric data 
Inal-Ince [36] 2010 
Cross-
section 
study 
22 
male only stable 
COPD 
62.5 
(6.5) 
49.7 
(28.5) % 
FSS, FIS 
multi-
dimension 
BODE, SAFE 
correlation used for 
analyses of grading 
scales  
Wong [44] 2010 
Cross-
section 
study 
42 
COPD 
participating in 
Pulmonary 
Rehabilitation 
72.9 
(6.5) 
47.8 
(16.3)% - 
only for 
n=14 
MFI-20 
multi-
dimension 
age (RA, RM), 
negative correlation 
with anxiety (RM) 
Not homogenous 
population, during 
intervention process.  
Jones [45] 2011 
population, 
Cross-
section 
study 
1817 
40-80 yrs COPD, 
no other 
respiratory or 
unstable 
cardiovascular 
disease  
64.9 
(9.6) 
56.7 
(20.1) 
FACIT-
Fatigue 
uni-
dimension 
number of co-
morbidities, but not 
associated with 
presence of 
cardiovascular co-
morbidity 
Large epidemiological 
study, fatigue was a 
secondary outcome 
only. Differences in 
fatigue between the 
co-morbidity groups 
were analysed 
Al-shair [43] 2011 
Cross-
section 
study 
120 stable COPD 66 (6.7) 
52.5 
(18.5)% 
MCFS 
multi-
dimension 
IL-6, CRP, TNF-α, 
TNF-α-R1 and TNF-α-
R2 do not correlate 
with fatigue 
adequate sample size, 
not clear if correction 
was used for multiple 
correlation analyses 
% pred. FEV1: percent predicted Forced Expiratory Volume in one second; 6MWT: 6 Minute Walk Test; BDI: Beck Depression Inventory; BESC: Bronchitis-Emphysema Symptom Checklist; CRP: 
C – Reactive Protein; FACIT-F: Functional Assessment of Chronic Illness Therapy- Fatigue; FIS: Fatigue Impact Scale; FSS: Fatigue Severity Scale; IL 6: Interleukin 6; MCRS- Manchester COPD 
Fatigue Score; MFI-20: Multidimensional Fatigue Inventory (GF- General Fatigue, PF – Physical Fatigue, RA- Reduced Activity, RM- Reduced Motivation, MF- Mental Fatigue subscales); MRC: 
Medical Research Council Dyspnoea Grade; NRS: Numeric Rating Scale; POMS-F: Profile of Moods Scale- Fatigue; PR: Pulmonary Rehabilitation; TNF-α: tumor necrosis factor-alpha (R1 &2: 
receptorn1& 2); VAS: Visual Analogue Scale.  
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In 4 studies, the robust multiple regression analyses were used to identify predictive variables of fatigue. Using a 
stepwise regression analysis 42% of the variance of fatigue (SF-36 fatigue) was explained by dyspnoea (self 
reported measure) and physical symptoms (MSAS) [7]. A later study of 128 moderate COPD patients, also 
identified dyspnoea together with mood as predictive factors (R
2
=0.47) [10]. Similarly, around 40% of fatigue in 
men was explained by dyspnoea and depression and in women by dyspnoea, depression and sleep quality [4]. 
Other study indicated that predictive factors of fatigue are annual exacerbation rate and time spent outdoor [13]. 
However, the reduced time outdoor may be considered as a consequence of fatigue rather than its predictor. 
Nevertheless, these studies may be criticised for either lack of validated tools or choice of linear regression for 
non-continuous variables. Furthermore, none of these studies explored predictive factors considering the 
multidimensional nature of fatigue. One recently published study revealed that fatigue in COPD, when 
considered as a multi-component construct, can be explained by a different combination of variables [21]. This 
study drew together the psychological and physiological aspects of fatigue to develop working models of 
COPD-RF by using comparative data from healthy age-matched subjects. Logistic regression analyses were 
used to explore possible predictors of fatigue components of the MFI-20. Predictors of General Fatigue were 
depression, muscle strength and end SpO2 (R
2
= .62); of Physical Fatigue: depression, % predicted FEV1, Shuttle 
Walk Test and age (R
2
= .57); of Reduced Activity: % predicted FEV1, BMI and depression (R
2
= .36); of 
Reduced Motivation: end SpO2, depression and RPE (R
2
 = .37) and of Mental Fatigue: depression and end SpO2 
(R
2
= .38). This study highlighted the importance of the multi-component construct in exploring the mechanisms 
of COPD-RF. For more details see table 5. 
In conclusion, the causes of fatigue may be sought in a combination of several psychological and physiological 
factors, which reflects the multidimensional nature of fatigue. However, only the minority of studies explored 
predictors of fatigue using multivariate analysis. It appears that a combination of depression, exercise capacity, 
muscle strength, airway limitation, blood oxygenation, BMI, dyspnoea and sleep quality may predict different 
dimensions of COPD-RF. Although, hitherto research goes some way towards explaining the mechanistic 
pathways of fatigue in COPD, there are many areas requiring further elucidation.  
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Table 5. Predictors of fatigue in COPD according to regression analyses- evidence summary. 
 
First 
author 
Year 
published 
Study 
type 
Sample 
size 
Study population 
Mean age 
(SD)        
% pred. 
FEV1 
(SD) 
Fatigue 
assess. 
tool 
Tool type 
Regression 
type 
Regression predictors 
General 
comments 
Gift [7] 1999 
Cross-
section 
study 
104 
stable COPD, not 
smoking, no 
psychologic diseases 
60 
22.6 
(6.8)% 
fatigue 
subscale 
SF-36 
subscale of 
QoL scale 
stepwise 
multiple 
SF-36 fatigue: dyspnoea, 
physical symptoms (42%); lack 
of energy: physical symptoms, 
BSI somatisation and dyspnoea 
(66%) 
Not validated 
tools used for 
regression 
analysis 
Kapella 
[4] 
2006 
Cross-
section 
study 
130 
moderate-to severe 
stable COPD, FEV1 
predicted <70%, no 
Asthma, surgery or 
Pulmonary 
Rehabilitation 
recently 
68.7(6.7) -
69.5(5.8) 
44.5 
(17.9)%- 
46.1 
(18.4) % 
NRS 
fatigue 
 numerical 
grading 
scale 
stepwise 
multiple 
For men: CRQ dyspnoea, 
depressive mood; in women: 
sleep quality, CRQ dyspnoea, 
depressive mood 
Not validated 
tools used for 
regression 
analysis 
Baghai- 
Ravary 
[13] 
2008 
cohort 
study 
107 (86 
in 
regressi
on) 
stable COPD, 
FEV1/FVC <70% 
69.4 (8.2) 
53.1 
(21.1)% 
FACIT-
Fatigue 
uni-
dimension 
multiple 
linear 
time spent outdoors, VAS 
dyspnoea, exacerbation rate, 
CES-D 
linear regression 
was used for non-
continuous 
variables  
Lewko 
[21] 
2009 
Cross-
section 
study 
59 
stable COPD, no other 
significant co-
morbidities 
 69.9 (8.4) 
46.5 
(20.0) %  
MFI-20 
multi-
dimension 
stepwise 
logistic 
GF: HADS depr., muscle torque, 
post exercise SpO2; PF: HADS 
depr., % pred. FEV1, ISWT, age; 
RA:  % pred. FEV1, BMI, HADS 
depr.; RM: Borg exertion, HADS 
depr., post exercise SpO2; MF: 
HADS depr., post exercise SpO2  
Arbitrary fatigue 
cut point, multi-
dimension fatigue 
analyses, small 
sample size for 
selected 
regression 
analyses 
% pred. FEV1: percent predicted Forced Expiratory Volume in one second; BSI: Brief Symptom Inventory; BMI: Body Mass Index; CES-D: Centre of Epidemiological Studies Depression Scale; 
CRQ: Chronic Respiratory Questionnaire; HADS: Hospital Anxiety and Depression Scale (depr: depression); ISWT: Incremental Shuttle Walk Test; NRS: Numerical Rating Scale; QoL: Quality of 
Life; SF-36: Short Form 36; FACIT-F: Functional Assessment of Chronic Illness Therapy- Fatigue; MFI-20: Multidimensional Fatigue Inventory (GF- General Fatigue, PF – Physical Fatigue, RA- 
Reduced Activity, RM- Reduced Motivation, MF- Mental Fatigue subscales); Sp02:  Blood oxygen saturation; VAS: Visual Analogue Scale 
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Coping and treatment strategies for fatigue  
As has been shown earlier fatigue is an important and highly prevalent symptom in COPD, which can persist 
over time. Hence, the majority of patients develop some coping strategies. Over time when disease progresses, 
patients appear to learn how to accept and even cope with the feeling;  “It upsets me but I am not going let it 
depress me” [5]. In addition, patients with COPD and asthma develop problem- and emotion-focused strategies. 
The most commonly used problem-focused strategies identified by patients were pacing, protecting oneself, and 
maintaining activities within limitations (energy conservation); regular exercising and keeping active (energy 
utilisation) and resting and relaxation (energy restoration). Both COPD and asthma patients found helpful 
methods of managing their emotional response to the problem: 53% of patients used a ‘positive approach’, 42% 
accepted their condition and physical limitations, other methods used were distracting (25%) and normalising 
(36%). However, for some patients, fatigue remained an important problem with reports of ‘constantly fighting 
fatigue’ or complaints of ‘tired of being tired’.   
One recent study evaluated an effect of breathing exercises on fatigue in COPD patients [46]. The study 
included 60 older (>70years) COPD in-patients. Patients were randomised to either experimental or control 
groups with routine treatment and assessed using the FSS. Patients in the experimental group had to perform 
respiratory exercises 4 times a day for 10 days; these included pursed lips breathing, diaphragm respiration and 
effective cough. There was no difference in FSS between the groups at baseline and the majority (90%) 
experienced severe fatigue. After 10 days fatigue had significantly diminished in both groups with much higher 
decrease in the experimental compare with control group. The reduction in fatigue sensation may be due to 
decreased work of breathing by using well established breathing control and chest clearance techniques in 
patients during exacerbation of COPD. However, the study is generally of poor quality, lacking clear 
explanation of randomisation, the tool validation method (there are a few references missing) or the cohort 
descriptive data. Therefore, the findings of this study are very difficult to interpret and cannot be regarded as 
robust evidence. Nevertheless, effective therapeutic strategies are required which will help patients to relieve 
unpleasant symptom of fatigue. One meta-analysis by Lacasse and colleagues [47] demonstrated that the fatigue 
subscale of a QoL measure is significantly improved followed a PR programme. Moreover, one congress report 
of fatigue following a course of PR confirms that the number of fatigued patients can be significantly reduced 
after PR [48]. However, a small randomised control trial of 26 severe COPD patients showed that after 12 
weeks of PR there were no significant improvements for fatigue (FIS) in either rehabilitation and control groups 
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[49]. Nevertheless, there were no changes reported for other outcome measures and the study was underpowered 
with only 12 patients completing PR. Although there are some indications that PR may be one of the clinical 
interventions attenuating fatigue in COPD patients, it is not clear which elements of this comprehensive 
programme may play any role in the treatment process of fatigue. A recent observational study looked at fatigue 
in 251 COPD as a secondary result of a large PR randomised trial [50]. Fatigue was assessed by the SF-36 
vitality and a cut point for a high fatigue was determined arbitrary prior the study. Thirty nine percent of patients 
(n= 97) had high fatigue at baseline. Regrettably, there is no data presented for SF-36 vitality in follow up and it 
is unknown how many patients changed their score after PR. Nevertheless, after 3 months of PR, high fatigue 
patients improved significantly compared to those with low fatigue on QoL scale. However, unlike in the low 
fatigue group, the improvements in a walked distance or endurance time achieved at the end of PR were not 
sustained after 1 year in the high fatigue group. This may suggest that fatigue is an important factor in long-term 
exercise tolerance maintenance. Therefore, fatigue management strategies may be crucial for long term benefits 
of PR. Nevertheless, the study uses one of the subscales of a generic QoL questionnaire for fatigue assessment. 
Hence, the results may give some indications for future research rather than being valid findings. See studies’ 
summary in table 6. 
In summary, coping strategies appear to be used by patients for management of fatigue and fatigue may be 
altered by PR. However, there is a lack of good quality RCTs to indicate the effectiveness of treatments of 
multidimensional fatigue.   
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Table 6. Coping and treatment strategies for fatigue- evidence summary. 
 
First author 
Year 
published 
Study type Sample size 
Study 
population 
Control 
group 
Mean age 
(SD)        
% pred. 
FEV1 (SD) 
treatment/ 
strategy 
Fatigue 
Tool  
Effect 
General 
comments 
Intervention v. Control 
Small [5] 1999 qualitative 17 COPD  no 62.8 (9.9) 
34.8 (18.9) 
%  
pacing, 
protection, 
energy 
conservation, 
keeping 
active, resting 
Open 
question 
interview 
not assessed 
Focus group 
consists both 
COPD and 
asthma patients 
Lacasse [47] 2007 meta-analysis 
326 
intervention 
v. 292 
control 
COPD home 
base, in- and 
out- patient,  
usual care 
not 
presented 
not 
presented 
4-52 weeks 
Pulmonary 
Rehabilitation 
CRQ 
fatigue 
statistically 
significant 
improvement 
the intervention 
group 
No fatigue 
specific 
assessment 
included 
Peters [48] 2008 cohort study 159 COPD no 
data not 
available 
data not 
available 
Pulmonary 
Rehabilitation 
CIS 
significant 
reduction in 
number of 
fatigued 
patients after 
intervention 
only congress 
abstract 
published, no 
fatigue specific 
assessment 
Theander [49] 2009 RCT 
12 
intervention 
v. 14 control 
COPD, ≤75yrs 
old, 25-60% 
pred. FEV1 
yes 
66 (6) v. 64 
(6) 
35.1 (7.6) 
v. 32.3 
(9.5)% 
12 week 
Pulmonary 
Rehabilitation 
FIS 
no significant 
improvements 
in either 
intervention or 
control 
study 
underpowered, 
there were no 
improvements 
in any outcome 
measures 
Zakerimoghadam 
[46] 
2011 
semi-
experimental 
30 
intervention 
v. 30 control 
hospitalised 
mild-to- 
moderate 
COPD, no 
psychotic 
confusion  
routine 
treatment 
data not 
available 
data not 
available 
Breathing 
exercises 
FSS 
significant 
reduction in 
number of 
fatigued 
patients after 
intervention 
unclear 
randomisation 
method or 
cohort 
characteristics 
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Baltzan [50] 2011 cohort study 251 
COPD, low 
and high 
fatigue 
groups 
no 
63.7(9.2)-
67.1(8.2) 
43.1 
(12.6)-45.9 
(13.3) % 
3 month 
Pulmonary 
Rehabilitation 
SF- 36 
vitality  
both low and 
high fatigue  
groups 
improved on all 
outcomes, but 
High fatigue did 
not sustain 
exercise 
tolerance 
improvement in 
1 year  
secondary 
analysis of RCT, 
no fatigue 
specific 
assessment 
% pred. FEV1: percent predicted Forced Expiratory Volume in one second; CIS: Checklist Individual Strength;  CRQ: Chronic Respiratory Questionnaire; FIS: Fatigue Impact Scale; FSS: Fatigue 
Severity Scale; SF-36: Short Form 36 
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Discussion and conclusions 
This literature review revealed that fatigue is a highly prevalent symptom in COPD, which may negatively 
impact patient’s functional performance and QoL, affects ADLs or time spent outdoor. The review identified 
that fatigue is higher in COPD compared with healthy subjects and all components of fatigue may be affected. 
Although the studies’ findings are consistent, they were based on few publications with sometimes flawed data, 
particular when considering a selection of healthy subjects. Future data obtained from larger population studies 
may widen knowledge regarding differences in fatigue between COPD and healthy populations. Interestingly, 
unlike in healthy population where women experience more fatigue [51], most of the studies presented in this 
review revealed no gender differences in fatigue in COPD population. This may indicate that mechanisms 
involved in fatigue in COPD equally affect both men and women. However, fatigue experience may be more 
intense and distressing for COPD women compared to men [4], it is similar to health population. 
Furthermore, this literature showed that various patho-physiological and psychological factors may contribute to 
the increased fatigue in COPD. There was a strong indication that factors such as dyspnoea and depression may 
be predictors of fatigue. Depression is common co-morbidity in COPD [52] and inevitably affects all aspects of 
fatigue. Also, dyspnoea and fatigue are both syptoms of COPD [8] and they share some similar assessment 
features [53] or pathophysiological mechanisms. This includes involvement of the CNS and central fatigue 
[54;55], anxiety-depression disorders [52], hypoxaemia and hypercapnia, early lactic acid onset, skeletal and 
respiratory muscle weakness [53;56]. Other factors indicated by research to be involved in COPD-Related 
Fatigue are age, airway obstruction severity, exacerbation rate, sleep quality, exercise tolerance and muscle 
strength. More comprehesive anlyses of psychological, physical, behavioral and motivational fatigue revealed 
that each component could be explained by different variations. For instance, physical performance factors such 
as muscle strength or distance walked were associated more with physical and general aspects of fatigue; 
psychological factors such as depression and measure of oxygen level were associated with motivational and 
mental fatigue. Although presently there is no consensus regarding the mechanistic pathways of fatigue in 
COPD, there are some indications for future investigation of fatigue pathomechanism. 
Furthermore, various fatigue coping methods are identified by patients, but there is little knowledge about 
management and treatment strategies focusing on this important and debilitating symptom. Pulmonary 
Rehabilitation, a well established treatment method for COPD [2] showed improvement in fatigue component of 
A Comprehensive Literature Review of COPD-Related Fatigue                                                          CRMR 2012 
 
27 
 
QoL [47]. However, the studies evaluating specifically subjective fatigue in COPD failed to unambiguously 
confirm similar improvement. Future well-powered randomised trials will bring insight to this area of research. 
Some other areas identified by research, such as intensity, pattern and frequency of fatigue, lacked good quality 
data or showed contradictive findings to draw clear conclusions.  
Concluding, data extraction and analysis for this review was particularly difficult as authors’ definition of 
fatigue, tools and interpretation differed between most of the studies. This paper reveals lack of unity and 
consistency within literature of COPD-Related Fatigue and future research should use validated and fatigue 
specific assessment tools to provide more robust data in this area. This review draws all relevant knowledge and 
systematise existing evidence for clinical and research use. Gaps identified in literature may help develop future 
research studies and treatment strategies for COPD-Related Fatigue. 
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